ReviewCanadian journal of gastroenterology & hepatology2022

Glucocorticosteroids and the Risk of NAFLD in Inflammatory Bowel Disease.

Sara Jarmakiewicz-Czaja et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.